TRACP as an osteopontin phosphatase

被引:62
作者
Andersson, G [1 ]
Ek-Rylander, B [1 ]
Hollberg, K [1 ]
Ljusberg-Sjölander, J [1 ]
Lång, P [1 ]
Norgård, M [1 ]
Wang, YL [1 ]
Zhang, SJ [1 ]
机构
[1] Huddinge Univ Hosp, Div Pathol, Karolinska Inst, IMPI, SE-14186 Huddinge, Sweden
关键词
purple acid phosphatase; uteroferrin; osteoclasts; adhesion; migration; bone;
D O I
10.1359/jbmr.2003.18.10.1912
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TRACP is synthesized as a latent proenzyme requiring proteolytic processing to attain maximal phosphatase activity. Excision of an exposed loop domain abolishes the interaction between the loop residue Asp146 and a ligand to the redox-sensitive iron of the active site, most likely Asn91, providing a mechanism for the enzyme repression. Both cathepsin K and L efficiently cleave in the loop domain and activate the latent enzyme, and we propose that cathepsin K acts as a physiological activator of TRACP in osteoclasts, whereas cathepsin L might fulfill a similar role in different types of macrophages. Considering the rather broad substrate specificity of TRACP, a tight regulation of its activity in the cell appears warranted. Besides proteolytic cleavage, the enzyme should need a specific local environment with a slightly acidic pH and reducing equivalents to keep the enzyme fully active. Cellular subcompartments where these required conditions prevail are potential subcellular site(s) of TRACP action. Of bone phosphoproteins shown to be substrates for TRACP, both osteopontin and bone sialoprotein are colocalized with TRACP in the resorption lacuna of the osteoclasts, and dephosphorylation of OPN impair its ability to promote adhesion as well as migration of osteoclasts in vitro. A role for TRACP as an osteopontin phosphatase in bone is therefore suggested. The expression of TRACP as well as OPN in other tissues with possible interactions between the two could suggest a more general function for TRACP as a regulator of OPN phosphorylation and bioactivity.
引用
收藏
页码:1912 / 1915
页数:4
相关论文
共 30 条
  • [1] The tartrate-resistant purple acid phosphatase of bone osteoclasts - A protein phosphatase with multivalent substrate specificity and regulation
    Andersson, G
    EkRylander, B
    [J]. ACTA ORTHOPAEDICA SCANDINAVICA, 1995, 66 : 189 - 194
  • [2] Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity
    Ashkar, S
    Weber, GF
    Panoutsakopoulou, V
    Sanchirico, ME
    Jansson, M
    Zawaideh, S
    Rittling, SR
    Denhardt, DT
    Glimcher, MJ
    Cantor, H
    [J]. SCIENCE, 2000, 287 (5454) : 860 - 864
  • [3] The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
    Chabas, D
    Baranzini, SE
    Mitchell, D
    Bernard, CCA
    Rittling, SR
    Denhardt, DT
    Sobel, RA
    Lock, C
    Karpuj, M
    Pedotti, R
    Heller, R
    Oksenberg, JR
    Steinman, L
    [J]. SCIENCE, 2001, 294 (5547) : 1731 - 1735
  • [4] Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival
    Denhardt, DT
    Noda, M
    O'Regan, AW
    Pavlin, D
    Berman, JS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (09) : 1055 - 1061
  • [5] EKRYLANDER B, 1994, J BIOL CHEM, V269, P14853
  • [6] EKRYLANDER B, 2003, IN PRESS MODULATION
  • [7] RGD-DIRECTED ATTACHMENT OF ISOLATED RAT OSTEOCLASTS TO OSTEOPONTIN, BONE SIALOPROTEIN, AND FIBRONECTIN
    FLORES, ME
    NORGARD, M
    HEINEGARD, D
    REINHOLT, FP
    ANDERSSON, G
    [J]. EXPERIMENTAL CELL RESEARCH, 1992, 201 (02) : 526 - 530
  • [8] Funhoff EG, 2001, CHEMBIOCHEM, V2, P355, DOI 10.1002/1439-7633(20010504)2:5<355::AID-CBIC355>3.0.CO
  • [9] 2-Q
  • [10] Mutational analysis of the interaction between active site residues and the loop region in mammalian purple acid phosphatases
    Funhoff, EG
    Ljusberg, J
    Wang, YL
    Andersson, G
    Averill, BA
    [J]. BIOCHEMISTRY, 2001, 40 (38) : 11614 - 11622